Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Applied BioCode, Inc. logo — The Ideal Choice for Cost-Effective High Throughput Syndromi...

Applied BioCode, Inc.

The Ideal Choice for Cost-Effective High Throughput Syndromic Panels

Founded 2008 United States Santa Fe Springs, United States 60 employees Venture round Total: $17.51M Biotechnology, Health Care +1

General Information

Company Name Applied BioCode, Inc.
Founded Year 2008
Location United States Santa Fe Springs, United States
Founders / Decision Makers
Team member
Employees 60
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Applied BioCode, Inc.. To contact Applied BioCode, Inc., visit apbiocode.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Applied BioCode, Inc. compare?

A PDF of Applied BioCode, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Applied BioCode, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Applied BioCode, Inc.

Applied BioCode, Inc. is a biotechnology company based in Los Angeles, California that focuses on the development, manufacturing, and commercialization of multiplex diagnostic testing products for in vitro diagnostics, research, and industrial applications. The company has pioneered the Barcoded Magnetic Beads (BMB) technology, combining digital barcodes with immunochemistry and molecular probes to enable the accurate identification of a high number of biological targets. Applied BioCode, Inc. targets the $4.5 billion molecular diagnostic infectious disease segment, offering assays for gastrointestinal infections, respiratory infections, and other high-value diseases. Founded in 2008, the company has achieved significant milestones in product development and regulatory clearances. It received FDA Clearance for the BioCode® MDx-3000 system, including the Gastrointestinal Pathogen Panel (GPP) and the Respiratory Pathogen Panel (RPP), as well as the CE-Mark for the GPP for use in European countries. Notably, in response to the COVID-19 pandemic, Applied BioCode, Inc. has developed the BioCode® SARS-CoV-2 Assay, authorized by the FDA under the Emergency Use Authorization (EUA). With its innovative technology and product portfolio, the company has attracted investment, including a $9.26M Venture Round investment in April 2016. Applied BioCode, Inc. has also established partnerships across various diagnostic and pharmaceutical applications, further indicating its potential for growth and impact within the biotechnology industry.

Business keywords: Molecular Diagnostics, In Vitro Diagnostics, Multiplex Testing, Infectious Diseases, Syndromic Panels, Biomedical Technology, Clinical Diagnostics, Microbiology, Pathogen Detection, Diagnostic Testing, Bioassay Solutions, Immunoassay, Life Science Research

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $9.26M -
08 Apr 2016
Venture Round $1.25M -
06 Dec 2012
Venture Round $7.00M -
26 Nov 2012

Applied BioCode, Inc. Alternatives & Competitors

View All Alternatives
Applied BioCode, Inc. vs
Mobidiag, A Hologic Company
Mobidiag, A Hologic Company Finland

Molecular diagnostics for infectious diseases and antibiotic resistance management.

Debt Financing
96 employees
Biotechnology, Health Care
Compare Applied BioCode, Inc. vs Mobidiag, A Hologic Company
Applied BioCode, Inc. vs
SHENZHEN UNI-MEDICA TECHNOLOGY
SHENZHEN UNI-MEDICA TECHNOLOGY

LIFE SCIENCE TECHNOLOGY

Corporate Round
3 employees
Biotechnology, Health Care
Applied BioCode, Inc. vs
Genomtec SA
Genomtec SA Poland

Molecular diagnosis everywhere, at the right time and for the right price.

Grant
26 employees
Biotechnology, Health Care
Compare Applied BioCode, Inc. vs Genomtec SA
View all alternatives

FAQ About Applied BioCode, Inc.

The Ideal Choice for Cost-Effective High Throughput Syndromic Panels
Applied BioCode, Inc. was founded in 2008.
Applied BioCode, Inc. is headquartered in Santa Fe Springs, United States.
Applied BioCode, Inc. operates in Biotechnology, Health Care and Life Sciences. Its work centres on Molecular Diagnostics, In Vitro Diagnostics, Multiplex Testing and Infectious Diseases.
Applied BioCode, Inc. has approximately 60 employees.
Applied BioCode, Inc. has completed 3 funding rounds, raising a total of $17.51M. The latest funding stage is Venture round.
Top alternatives and competitors to Applied BioCode, Inc. include Mobidiag, A Hologic Company, SHENZHEN UNI-MEDICA TECHNOLOGY , Genomtec SA, Quidel, Qvella Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Applied BioCode, Inc. and Mobidiag, A Hologic Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Applied BioCode, Inc., https://bouncewatch.com/company/applied-biocode-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes